">
It's too soon to say Merck has momentum. Many people felt the Irvin case was a weak case to begin with. It was a short-term usage case.
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

It’s too soon to say Merck has momentum. Many people felt the Irvin case was a weak case to begin with. It was a short-term usage case.

Facebooktwitterredditpinterestlinkedintumblr

Related Quotes

popup close button